136
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Tofacitinib for the Treatment of Steroid-Induced Rosacea

, , & ORCID Icon
Pages 2519-2521 | Received 12 Oct 2022, Accepted 10 Nov 2022, Published online: 23 Nov 2022

Figures & data

Figure 1 Changes of skin lesions and itching scale during tofacitinib treatment.(A) Image of skin lesions and itching scale before patient started oral tofacitinib. (B) Image of skin lesions and itching scale when patient started oral tofacitinib. (CE) Images of skin lesions and itching scale at week 2,4,6. (F) Image of skin lesions and itching scale at week 18.

Figure 1 Changes of skin lesions and itching scale during tofacitinib treatment.(A) Image of skin lesions and itching scale before patient started oral tofacitinib. (B) Image of skin lesions and itching scale when patient started oral tofacitinib. (C–E) Images of skin lesions and itching scale at week 2,4,6. (F) Image of skin lesions and itching scale at week 18.